Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Meyfour

Showing results (41-50 of 45) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 45 results.
Aging and Disease|December 9, 2021
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's DiseaseMorteza Abyadeh, Vivek Gupta, Veer Gupta, et al.
Reproductive Biomedicine Online|November 4, 2025
Comparative proteomic analysis of receptive and non-receptive endometria-derived uterine fluid suggests a panel for endometrial receptivity assessmentFarnoosh Saraee, Faezeh Shekari, Ashraf Moini, et al.
Drug Delivery and Translational Research|April 10, 2024
Progress of antibody-drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studiesAli Hussein Mer, Yousef Mirzaei, Fatemeh Misamogooe, et al.
Life Sciences|July 13, 2024
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidenceMohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 23, 2023
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancerZohreh Najminejad, Fatemeh Dehghani, Yousef Mirzaei, et al.
Pageof 5

Showing results (41-50 of 45) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 45 results.
Aging and Disease|December 9, 2021
Comparative Analysis of Aducanumab, Zagotenemab and Pioglitazone as Targeted Treatment Strategies for Alzheimer's DiseaseMorteza Abyadeh, Vivek Gupta, Veer Gupta, et al.
Reproductive Biomedicine Online|November 4, 2025
Comparative proteomic analysis of receptive and non-receptive endometria-derived uterine fluid suggests a panel for endometrial receptivity assessmentFarnoosh Saraee, Faezeh Shekari, Ashraf Moini, et al.
Drug Delivery and Translational Research|April 10, 2024
Progress of antibody-drug conjugates (ADCs) targeting c-Met in cancer therapy; insights from clinical and preclinical studiesAli Hussein Mer, Yousef Mirzaei, Fatemeh Misamogooe, et al.
Life Sciences|July 13, 2024
Nectin-4-directed antibody-drug conjugates (ADCs): Spotlight on preclinical and clinical evidenceMohammad Javad Khosravanian, Yousef Mirzaei, Ali Hussein Mer, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|March 23, 2023
Clinical perspective: Antibody-drug conjugates for the treatment of HER2-positive breast cancerZohreh Najminejad, Fatemeh Dehghani, Yousef Mirzaei, et al.
Pageof 5